• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中黑质致密部神经元胰岛素受体免疫反应性丧失。

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.

作者信息

Moroo I, Yamada T, Makino H, Tooyama I, McGeer P L, McGeer E G, Hirayama K

机构信息

Department of Neurology, Chiba University School of Medicine, Japan.

出版信息

Acta Neuropathol. 1994;87(4):343-8. doi: 10.1007/BF00313602.

DOI:10.1007/BF00313602
PMID:8017169
Abstract

Immunohistochemistry using both a newly developed polyclonal, and a commercially available monoclonal, anti-insulin receptor antibody was done on the midbrain from cases of idiopathic Parkinson's disease (PD), Alzheimer's disease, amyotrophic lateral sclerosis, vascular parkinsonism and non-neurological controls. Both antibodies gave identical patterns of neuronal staining. The neurons of the oculomotor nucleus were immunopositive in all the brains. However, the neurons in the pars compacta of the substantia nigra, paranigral nucleus, parabrachial pigmental nucleus, tegmental pedunculopontine nucleus, supratrocheal nucleus, cuneiform nucleus, subcuneiform nucleus and lemniscus medialis, which were positive in other diseases and in non-neurological controls, were not stained by these antibodies in PD brains. These results suggest that, in PD, a dysfunction of the insulin/insulin receptor system may precede death of the dopaminergic neurons.

摘要

使用新开发的多克隆抗体和市售单克隆抗胰岛素受体抗体,对特发性帕金森病(PD)、阿尔茨海默病、肌萎缩侧索硬化症、血管性帕金森综合征病例以及非神经学对照的中脑进行免疫组织化学检测。两种抗体给出了相同的神经元染色模式。动眼神经核的神经元在所有大脑中均呈免疫阳性。然而,黑质致密部、黑质旁核、臂旁色素核、被盖脚桥核、滑车神经上核、楔形核、楔下核和内侧丘系中的神经元,在其他疾病和非神经学对照中呈阳性,但在PD大脑中未被这些抗体染色。这些结果表明,在PD中,胰岛素/胰岛素受体系统功能障碍可能先于多巴胺能神经元死亡。

相似文献

1
Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.帕金森病中黑质致密部神经元胰岛素受体免疫反应性丧失。
Acta Neuropathol. 1994;87(4):343-8. doi: 10.1007/BF00313602.
2
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.人脑黑质。II. 帕金森病中含多巴胺神经元的丢失模式。
Brain. 1999 Aug;122 ( Pt 8):1437-48. doi: 10.1093/brain/122.8.1437.
3
An altered histaminergic innervation of the substantia nigra in Parkinson's disease.帕金森病中黑质组胺能神经支配的改变。
Exp Neurol. 2000 May;163(1):20-30. doi: 10.1006/exnr.2000.7362.
4
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.帕金森病黑质致密部神经元中的神经丝信使核糖核酸减少。
J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304.
5
Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.对照和帕金森病大脑黑质中区域多巴胺转运体基因表达
J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):164-9. doi: 10.1136/jnnp.65.2.164.
6
Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.进行性核上性麻痹会影响黑质致密部和网状部。
Exp Neurol. 1997 Mar;144(1):183-92. doi: 10.1006/exnr.1997.6415.
7
Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中基底神经节和黑质的免疫细胞化学研究。
Neuroscience. 1988 May;25(2):419-38. doi: 10.1016/0306-4522(88)90249-7.
8
trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.正常人类大脑及帕金森病患者黑质中trkB信使核糖核酸的表达:一项原位杂交研究
Neuroscience. 1998 Oct;86(3):813-26. doi: 10.1016/s0306-4522(98)00126-2.
9
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.线粒体 DNA 缺失在多巴胺能神经元内的积累引发神经保护机制。
Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.
10
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.帕金森病1-甲基-4-苯基-1,2,3,6-四氢吡啶/丙磺舒渐进性神经退行性小鼠模型黑质致密部神经元凋亡的早期迹象。
Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14.

引用本文的文献

1
Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease.有氧运动引起帕金森病患者体液生物标志物的变化。
NPJ Parkinsons Dis. 2025 Jul 1;11(1):190. doi: 10.1038/s41531-025-01042-8.
2
Exploring the link between estimated glucose disposal rate and Parkinson's disease: cross-sectional and mortality analysis of NHANES 2003-2016.探索估计的葡萄糖处置率与帕金森病之间的联系:2003 - 2016年美国国家健康与营养检查调查的横断面研究及死亡率分析
Front Aging Neurosci. 2025 Apr 4;17:1548020. doi: 10.3389/fnagi.2025.1548020. eCollection 2025.
3
Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson's Disease.

本文引用的文献

1
Regulation of food intake and body weight by insulin.胰岛素对摄食和体重的调节。
Diabetologia. 1981 Mar;20(Suppl 1):274-280. doi: 10.1007/BF00254493.
2
Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease.
Neurology. 1993 Feb;43(2):372-6. doi: 10.1212/wnl.43.2.372.
3
Reduction of food intake and body weight by chronic intraventricular insulin infusion.通过慢性脑室内注射胰岛素减少食物摄入量和体重。
Brain Res Bull. 1984 May;12(5):571-5. doi: 10.1016/0361-9230(84)90174-6.
胰岛素与Toll样受体4抑制剂改善帕金森病大鼠模型的运动障碍
Iran J Pharm Res. 2024 Jun 11;23(1):e144200. doi: 10.5812/ijpr-144200. eCollection 2024 Jan-Dec.
4
Frailty and Parkinson's disease: the role of diabetes mellitus.衰弱与帕金森病:糖尿病的作用
Front Med (Lausanne). 2024 May 30;11:1377975. doi: 10.3389/fmed.2024.1377975. eCollection 2024.
5
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
6
Targeting neuroendocrine abnormalities in Parkinson's disease with exercise.通过运动针对帕金森病中的神经内分泌异常
Front Neurosci. 2023 Sep 8;17:1228444. doi: 10.3389/fnins.2023.1228444. eCollection 2023.
7
Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery.用于中枢神经系统药物递送的鼻内聚合物和脂质基纳米载体
Pharmaceutics. 2023 Feb 23;15(3):746. doi: 10.3390/pharmaceutics15030746.
8
Brain insulin resistance linked Alzheimer's and Parkinson's disease pathology: An undying implication of epigenetic and autophagy modulation.脑胰岛素抵抗与阿尔茨海默病和帕金森病病理相关:表观遗传和自噬调节的持久影响。
Inflammopharmacology. 2023 Apr;31(2):699-716. doi: 10.1007/s10787-023-01187-z. Epub 2023 Mar 23.
9
Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.改善神经退行性疾病中葡萄糖代谢受损的潜在机制。
J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24.
10
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.胰高血糖素样肽1在阿尔茨海默病和帕金森病中的神经保护作用:深入综述
Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022.
4
Insulin dependent neurite outgrowth in cultured embryonic mouse brain cells.培养的胚胎小鼠脑细胞中胰岛素依赖的神经突生长。
Brain Res. 1983 Dec;313(2):315-8. doi: 10.1016/0165-3806(83)90231-6.
5
Structural differences between insulin receptors in the brain and peripheral target tissues.大脑和外周靶组织中胰岛素受体的结构差异。
J Biol Chem. 1983 Jul 25;258(14):8527-30.
6
Effect of insulin on central catecholamines.胰岛素对中枢儿茶酚胺的作用。
Brain Res. 1983 Feb 7;260(2):330-3. doi: 10.1016/0006-8993(83)90691-1.
7
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.肌萎缩侧索硬化症、帕金森病和阿尔茨海默病病因的统一假说。
Ann Neurol. 1981 Dec;10(6):499-505. doi: 10.1002/ana.410100602.
8
Stimulation of synaptosomal uptake of neurotransmitter amino acids by insulin: possible role of insulin as a neuromodulator.胰岛素对神经递质氨基酸突触体摄取的刺激作用:胰岛素作为神经调质的可能作用。
Biochem Biophys Res Commun. 1984 Mar 30;119(3):1198-204. doi: 10.1016/0006-291x(84)90903-3.
9
Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain.大鼠脑神经元培养物中胰岛素受体及胰岛素对去甲肾上腺素摄取的调节作用
J Biol Chem. 1985 Dec 15;260(29):15880-4.
10
Insulin in the brain.大脑中的胰岛素。
Annu Rev Physiol. 1987;49:335-47. doi: 10.1146/annurev.ph.49.030187.002003.